NEWEST CONTENT
-
ORIGINAL REPORTSChi et al.April 29, 2021
-
CORRESPONDENCESundar et al.April 29, 2021
-
CORRESPONDENCEHöcht et al.April 29, 2021
-
CORRESPONDENCESpratt et al.April 29, 2021
-
ORIGINAL REPORTSAlig et al.April 28, 2021
FEATURED CONTENT

RAPID COMMUNICATIONS
Palbociclib for Residual High-Risk Invasive HR-Positive and HER2-Negative Early Breast Cancer—The Penelope-B Trial
Loibl et al. | April 1, 2021
ASCO SPECIAL ARTICLES
Management of Dyspnea in Advanced Cancer: ASCO Guideline
Hui et al. | February 22, 2021
NEWS
Jonathan W. Friedberg Named Next Editor-in-Chief of the Journal of Clinical Oncology
July 27, 2020
SPONSORED CONTENT
Sponsored by Puma Biotechnology
Adjuvant Therapy in HER2-Positive, Hormone Receptor–Positive Breast Cancer
MOST READ
(Last 60 days)-
Key et al.
-
Reck et al.
-
Hutchings et al.
-
Loibl et al.

